Literature DB >> 22778840

Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression.

Nicole K Speed1, Heinrich J G Matthies, J Phillip Kennedy, Roxanne A Vaughan, Jonathan A Javitch, Scott J Russo, Craig W Lindsley, Kevin Niswender, Aurelio Galli.   

Abstract

Dopamine (DA) is a neurotransmitter implicated in multiple functions, including movement, cognition, motivation, and reward. The DA transporter (DAT) is responsible for clearing extracellular DA, thereby terminating DA neurotransmission. Previously, it has been shown that insulin signaling through protein kinase B/Akt regulates DAT function by fine-tuning DAT cell surface expression. Importantly, specific Akt isoforms (e.g., Akt1, Akt2) serve distinct physiological functions. Here, we demonstrate using isoform-specific Akt inhibitors that basal activity of Akt2, rather than Akt1, regulates DAT cell surface expression. Since Akt2 activation is mediated by insulin, these data further implicate insulin signaling as an important modulator of DAT function and dopaminergic tone.

Entities:  

Keywords:  Akt; Dopamine; insulin; transporter

Mesh:

Substances:

Year:  2010        PMID: 22778840      PMCID: PMC3368666          DOI: 10.1021/cn100031t

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  42 in total

1.  Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.

Authors:  C Saunders; J V Ferrer; L Shi; J Chen; G Merrill; M E Lamb; L M Leeb-Lundberg; L Carvelli; J A Javitch; A Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity.

Authors:  Uhna Sung; Subramaniam Apparsundaram; Aurelio Galli; Kristopher M Kahlig; Valentina Savchenko; Sally Schroeter; Michael W Quick; Randy D Blakely
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

3.  Trace amines: identification of a family of mammalian G protein-coupled receptors.

Authors:  B Borowsky; N Adham; K A Jones; R Raddatz; R Artymyshyn; K L Ogozalek; M M Durkin; P P Lakhlani; J A Bonini; S Pathirana; N Boyle; X Pu; E Kouranova; H Lichtblau; F Y Ochoa; T A Branchek; C Gerald
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

4.  Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice.

Authors:  H Cho; J L Thorvaldsen; Q Chu; F Feng; M J Birnbaum
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

5.  GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase.

Authors:  R Somwar; D Y Kim; G Sweeney; C Huang; W Niu; C Lador; T Ramlal; A Klip
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

6.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

7.  Association of AKT1 haplotype with the risk of schizophrenia in Iranian population.

Authors:  Sepideh N Bajestan; Amir H Sabouri; Masayuki Nakamura; Hiroshi Takashima; Mohammad R Keikhaee; Fatemeh Behdani; Mohammad R Fayyazi; Mohammad R Sargolzaee; Mahboobeh N Bajestan; Zahra Sabouri; Esmaeil Khayami; Sima Haghighi; Susan B Hashemi; Nobutaka Eiraku; Hamid Tufani; Hossein Najmabadi; Kimiyoshi Arimura; Akira Sano; Mitsuhiro Osame
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-06-05       Impact factor: 3.568

8.  Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.

Authors:  Effat S Emamian; Diana Hall; Morris J Birnbaum; Maria Karayiorgou; Joseph A Gogos
Journal:  Nat Genet       Date:  2004-01-25       Impact factor: 38.330

9.  PI 3-kinase regulation of dopamine uptake.

Authors:  Lucia Carvelli; José A Morón; Kristopher M Kahlig; Jasmine V Ferrer; Namita Sen; James D Lechleiter; L M Fredrik Leeb-Lundberg; Gerald Merrill; Eileen M Lafer; Lisa M Ballou; Toni S Shippenberg; Jonathan A Javitch; Richard Z Lin; Aurelio Galli
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

10.  Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B.

Authors:  Sun Sik Bae; Han Cho; James Mu; Morris J Birnbaum
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

View more
  12 in total

Review 1.  Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape.

Authors:  Margrith E Mattmann; Sydney L Stoops; Craig W Lindsley
Journal:  Expert Opin Ther Pat       Date:  2011-06-02       Impact factor: 6.674

2.  mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission.

Authors:  Olga I Dadalko; Michael Siuta; Amanda Poe; Kevin Erreger; Heinrich J G Matthies; Kevin Niswender; Aurelio Galli
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

Review 3.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

4.  Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Authors:  Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender
Journal:  Neurochem Int       Date:  2013-09-30       Impact factor: 3.921

5.  Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity.

Authors:  Martin Heni; Stephanie Kullmann; Emma Ahlqvist; Robert Wagner; Fausto Machicao; Harald Staiger; Hans-Ulrich Häring; Peter Almgren; Leif C Groop; Dana M Small; Andreas Fritsche; Hubert Preissl
Journal:  Diabetologia       Date:  2016-09-06       Impact factor: 10.122

6.  PKBβ/AKT2 deficiency impacts brain mTOR signaling, prefrontal cortical physiology, hippocampal plasticity and select murine behaviors.

Authors:  Sara Palumbo; Clare Paterson; Feng Yang; Veronica L Hood; Amanda J Law
Journal:  Mol Psychiatry       Date:  2020-12-16       Impact factor: 15.992

7.  Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding.

Authors:  Nicole Speed; Christine Saunders; Adeola R Davis; W Anthony Owens; Heinrich J G Matthies; Sanaz Saadat; Jack P Kennedy; Roxanne A Vaughan; Rachael L Neve; Craig W Lindsley; Scott J Russo; Lynette C Daws; Kevin D Niswender; Aurelio Galli
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

8.  Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis.

Authors:  Weixia Zhong; Seetha Chebolu; Nissar A Darmani
Journal:  Eur J Pharmacol       Date:  2021-03-26       Impact factor: 5.195

9.  Insulin Regulates the Activity of the High-Affinity Choline Transporter CHT.

Authors:  Katherine J Fishwick; R Jane Rylett
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

10.  SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.

Authors:  E Bowton; C Saunders; I A Reddy; N G Campbell; P J Hamilton; L K Henry; H Coon; D Sakrikar; J M Veenstra-VanderWeele; R D Blakely; J Sutcliffe; H J G Matthies; K Erreger; A Galli
Journal:  Transl Psychiatry       Date:  2014-10-14       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.